Heartseed

is a Japan-based biotechnology company that discovers and develops cardiac regenerative medicines for the treatment of heart diseases...
Read more
Heartseed President & CEO: Keiichi Fukuda

President & CEO

Keiichi Fukuda

CEO Approval Rating

90/100

Annual Revenue
<$1M
Employees
<10
Funding
$89.4M

News

Oct 01, 2025
BioSpace
Heartseed: Novo Breaks $598M Heartseed Pact Amid 'Decisive Restructuring' by New CEO
Sep 30, 2025
FierceBiotechIT
Heartseed: Novo dumps cell therapy partner Heartseed, calling off $598M collab amid restructuring .
Oct 31, 2023
Acrofan
Heartseed: Heartseed Succeeds in Stable Production of High Purity Cardiomyocytes Using iPS Cells from I Peace, A Major Step Forward in Advancing Autologous Cardi
Sep 11, 2023
FinanzNachrichten
Heartseed: Heartseed Inc.: Heartseed Announces the Presentation of HS-001, an Investigational Stem Cell-Derived Therapy for the Treatment of Advanced Heart Failure at the 71st Annual Meeting of the Japanese College of Cardiology
Sep 05, 2023
Business Wire
Press Release: Heartseed : Heartseed Enters into induced Pluripotent Stem Cell Purification Patent License Agreement for Commercialization of Cell Therapy
May 29, 2023
DealStreetAsia
Heartseed: Japan's biotech firm Heartseed raises $14.3m in Series D round
Mar 16, 2023
News-Medical
Heartseed: Albumedix and Heartseed announce Recombumin as a critical excipient in the manufacture of Heartseed's HS-001 investigational cell therapy as its first in-human trial commences
Feb 10, 2023
Life Care News
Heartseed: Heartseed and Novo Nordisk announce first patient dosed in
Mar 02, 2022
HEARTSEED Youtube Channel
HEARTSEED posted a video "CATCH JAPAN Regenerative Medicine for the Heart" on YOUTUBE
Jun 14, 2021
Global University Venturing
Heartseed: Heartseed finds series C beat - University Venturing: News, Data, and Events - Global University Venturing

Heartseed Competitors

1Metcela
2Cardior
3iHeart
4Regulus
5Moderna
6Arrakis Therapeutics

Trending Companies